Clinical Trials Related to Fibrolamellar Carcinoma

Related studies linked through entity extraction aliases.

Agnostic Therapy in Rare Solid Tumors

Status: RECRUITING
Phase: PHASE2

A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers

Status: RECRUITING
Phase: N/A

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

KAT-101 in Subjects With Hepatocellular Carcinoma (HCC)

Status: SUSPENDED
Phase: PHASE1/PHASE2

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

Status: RECRUITING
Phase: PHASE1/PHASE2

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

Status: RECRUITING
Phase: PHASE2

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Status: COMPLETED
Phase: PHASE1

Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)

Status: COMPLETED
Phase: PHASE2